TG Therapeutics Announces Long-term Follow-up Data from the Phase 2 Trial of Ublituximab in Patients with Multiple Sclerosis
MediciNova Announces MN-166 (ibudilast) Demonstrated a 26% Reduction in Confirmed Disability Progression
pharmaceutical investing Adamas Announces Publication of ADS-5102 Phase 2 Clinical Trial Results in Multiple Sclerosis Journal
pharmaceutical investing Corbus Gets Patent Covering Use of Anabasum for the Treatment of Rare Fibrotic Diseases
cannabis investing Phase 1 Clinical Trial Results Using Satipharm Capsules Published in International Medical Journal
pharmaceutical investing Adamas to Present New ADS-5102 Data from Phase 2 Trial in Walking Impairment Associated with Multiple Sclerosis
Homerun Resources Inc. Completes the Assignment of the CBPM Lease over the Guidoni Belmonte District Silica Mineral Rights
Charbone Hydrogene annonce des mise-a-jour sur le projet phare de Sorel-Tracy, franchissant plusieurs etapes cles cette semaine
CHARBONE Hydrogen Provides Update on Flagship Sorel-Tracy Project, Achieving Multiple Key Milestones This Week